El proyecto del IQAC-CSIC recibe una ayuda de un millón de euros en la convocatoria CaixaResearch de Investigación en Salud 2021.
Read moreEight researches led by or with the participation of scientists from the Spanish National Research Council (CSIC) have been selected by the “la Caixa” Foundation among the 30 projects of the Caixa...
Read moreLa spin off de la Universidad de Santiago de Compostela, AFFINImeter, dentro de un consorcio con 13 universidades europeas y una multinacional británica para desarrollar una infraestructura de apo...
Read moreAn ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity and services across geographies for global life scien...
Read moreThis investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID), like rheumatoid arth...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...
Read moreLudus Global ha desarrollado una plataforma orientada a la formación en seguridad y salud y ya ha conseguido posicionarse como un actor relevante dentro de los mercados de habla hispana
Read moreThe summer period has begun with some important news in the sector. Two of the most important biotech crowdfunding rounds of the year have been closed. And, Barcelona has announced the creation of a n...
Read moreSeqera Labs – the leading provider of data orchestration and workflow software for life sciences – announces it has raised $5.5 million USD in seed funding.
Read more'la Caixa' Foundation will provide €100,000 to the IrsiCaixa project, which aims to establish a diagnostic tool to better identify infections caused by HIV, SARS-CoV-2 and Mycobacterium tuberculosis...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read moreCon motivo del Día Mundial del Alzheimer, hablamos con Marta Barrachina, fundadora y directora general de ADmit Therapeutics, uno de nuestros socios que busca un diagnóstico precoz a esta enfermedad...
Read more